Hangzhou Sumgen Biotech has secured 220 million yuan ($32 million) in a Series B round of financing led by Addor Capital, while digital healthcare platform inCarey has raised $30 million Series B+ exclusively from Long Hill Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
